Abdul Hye
Overview
Explore the profile of Abdul Hye including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
2613
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bencze J, Seo W, Hye A, Aarsland D, Hortobagyi T
Free Neuropathol
. 2023 Jun;
1.
PMID: 37283665
Dementia is one of the major burdens of our aging society. According to certain predictions, the number of patients will double every 20 years. Although Alzheimer's disease (AD), as the...
2.
Thela L, Decloedt E, Zetterberg H, Gisslen M, Lesosky M, Gleich M, et al.
J Neurovirol
. 2023 Feb;
29(2):156-166.
PMID: 36790601
HIV-associated neurocognitive disorders (HAND) persist in the era of antiretroviral therapy (ART). Thus, ART does not completely halt or reverse the pathological processes behind HAND. Adjuvant mitigating treatments are, therefore,...
3.
Khosousi S, Hye A, Velayudhan L, Bloth B, Tsitsi P, Markaki I, et al.
Parkinsonism Relat Disord
. 2023 Feb;
108:105313.
PMID: 36739794
Parkinson's Disease (PD) is diagnosed clinically, and early PD is often challenging to differentiate from atypical parkinsonian disorders such as the Four-repeat (4R-) Tauopathies Progressive Supranuclear Palsy and Corticobasal Syndrome....
4.
Bougea A, Svenningsson P, Markaki I, Hye A, Mondello S
Front Neurol
. 2023 Feb;
14:1103116.
PMID: 36733314
No abstract available.
5.
Gibson L, Pollak T, Hart M, Heslegrave A, Hye A, Church A, et al.
J Neuropsychiatry Clin Neurosci
. 2023 Jan;
35(3):236-243.
PMID: 36710627
Objective: -methyl-d-aspartate receptor (NMDAR) encephalitis is an autoantibody-mediated neurological syndrome with prominent cognitive and neuropsychiatric symptoms. The clinical relevance of NMDAR antibodies outside the context of encephalitis was assessed in...
6.
Batzu L, Rota S, Hye A, Heslegrave A, Trivedi D, Gibson L, et al.
NPJ Parkinsons Dis
. 2022 Nov;
8(1):154.
PMID: 36371469
Early identification of cognitive impairment in Parkinson's disease (PD) has important clinical and research implications. The aim of our study was to investigate the role of plasma tau phosphorylated at...
7.
Veteleanu A, Pape S, Davies K, Kodosaki E, Hye A, Zelek W, et al.
Alzheimers Dement
. 2022 Sep;
19(4):1383-1392.
PMID: 36149090
Introduction: Down syndrome (DS) is associated with immune dysregulation and a high risk of early onset Alzheimer's disease (AD). Complement is a key part of innate immunity and driver of...
8.
Gibson L, Pollak T, Heslegrave A, Hye A, Batzu L, Rota S, et al.
J Parkinsons Dis
. 2022 Apr;
12(5):1527-1538.
PMID: 35466956
Background: Neuropsychiatric symptoms are common and important to people with Parkinson's disease (PD), but their etiology is poorly understood. Plasma neurofilament light (NfL) and p-tau181 are biomarkers of neuro-axonal degeneration...
9.
Imarisio A, Pilotto A, Garrafa E, Conforti F, Masciocchi S, Turrone R, et al.
Neurodegener Dis
. 2022 Mar;
21(5-6):109-116.
PMID: 35287127
Introduction: Previous studies reported increased plasma levels of cystatin C (Cys-C) in Parkinson's disease (PD) and claimed for a possible association with disease severity and progression. The aim of this...
10.
Xu J, Green R, Kim M, Lord J, Ebshiana A, Westwood S, et al.
Biomedicines
. 2021 Nov;
9(11).
PMID: 34829839
Background: physiological differences between males and females could contribute to the development of Alzheimer's Disease (AD). Here, we examined metabolic pathways that may lead to precision medicine initiatives. Methods: We...